DaVita Inc.
NYSE:DVAMedical - Care Facilities
+$1.60 today
- Market cap
- $10.18B
- Beta
- 0.91
- P/E (TTM)
- 18.2
- EPS (TTM)
- $11.60
Volume 1.12M
Average 0.84M
DVA Other Current Assets
Current assets not reported separately, such as prepaid expenses.
DaVita Inc.NYSE: DVA
Other Current Assets · Q2 FY2026 · quarter ended Jun 2026
Other current assets falls 15.8% from a year ago
Other current assets stood at $167.49M at the end of Q2 FY2026, down 15.8% from a year earlier and up 368.1% from the prior quarter. Over 3 fiscal years it compounded at -3.5% a year.
Context
- Other current assets amounted to 0.9% of total assets at the end of Q2 FY2026, down 0.2 pp from a year earlier.
- Other current assets increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether other current assets keeps falling in the next quarterly balance sheet after a -15.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 156.29M USD
- Year-over-year change
- -24.8%
- 4-year CAGR
- +13.8%
| Period | Period end | Other Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 156.29M | -24.8% |
| FY2024 | 2024-12-31 | 207.84M | +11.0% |
| FY2023 | 2023-12-31 | 187.22M | +7.8% |
| FY2022 | 2022-12-31 | 173.74M | +86.7% |
| FY2021 | 2021-12-31 | 93.06M | — |
Other Current Assets vs competitors
How DVA compares with its peers on the latest reported figures
- Peers report in different currencies, so other current assets is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -15.8% is the highest of 3, against a peer median of -29.2%.
- Other current assets amounts to 0.9% of total assets for DVA, versus a peer median of 2.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $724M USD | -20.1% | -8.1% | 3.7% | |
| Jun 2026 | €442.88M EUR | -38.3% | +14.2% | 1.4% | |
| Jun 2026 | $167.49M USD | -15.8% | -3.5% | 0.9% | |
| Peer median (excluding DVA) | — | -29.2% | +3.0% | 2.5% | |
Competitors are the stored peer set for DVA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 461.9M | 244.09M | 380.06M | 794.93M | 757.75M |
| Short-term Investments | 22.31M | 77.69M | 11.61M | 51.06M | 24.3M |
| Net Receivables | 2.41B | 2.55B | 2.42B | 2.56B | 2.96B |
| Inventory | 107.43M | 109.12M | 143.11M | 134.56M | 160.63M |
| Other Current Assets | 93.06M | 173.74M | 187.22M | 207.84M | 156.29M |
| Total Current Assets | 3.17B | 3.16B | 3.14B | 3.75B | 4.06B |
| Property, Plant & Equipment (Net) | 6.3B | 5.92B | 5.57B | 5.33B | 5.21B |
| Goodwill | 7.05B | 7.08B | 7.11B | 7.38B | 7.55B |
| Intangible Assets | 177.69M | 182.69M | 203.22M | 197.43M | 222.13M |
| Long-term Investments | 288.4M | 275.44M | 593.74M | 370.34M | 198.22M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 136.68M | 315.59M | 271.25M | 261.73M | 246.52M |
| Total Non-current Assets | 13.95B | 13.77B | 13.76B | 13.54B | 13.42B |
| Total Assets | 17.12B | 16.93B | 16.89B | 17.29B | 17.48B |
| Account Payables | 402.05M | 479.78M | 514.53M | 547.2M | 696.15M |
| Short-term Debt | 179.03M | 231.4M | 123.3M | 270.87M | 109.2M |
| Tax Payables | 53.79M | 18.04M | 28.51M | 69.31M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.24B | 1.35B | 1.42B | 1.53B | 1.09B |
| Total Current Liabilities | 2.4B | 2.62B | 2.64B | 2.97B | 3.14B |
| Long-term Debt | 8.73B | 8.69B | 8.27B | 9.18B | 12.34B |
| Deferred Tax Liabilities | 830.95M | 782.79M | 726.22M | 665.36M | 756.87M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 119.16M | 105.23M | 183.07M | 169.59M | (2.09B) |
| Total Non-current Liabilities | 12.35B | 12.08B | 11.51B | 12.22B | 13.18B |
| Total Liabilities | 14.75B | 14.7B | 14.15B | 15.19B | 16.32B |
| Common Stock | 97K | 90K | 89K | 90K | 69K |
| Retained Earnings | 354.34M | 174.49M | 598.29M | 1.53B | (328.43M) |
| Accumulated OCI | (139.25M) | (69.19M) | (52.08M) | (310.8M) | (122.78M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 1.62B | 1.51B | 1.69B | 1.97B | 1.81B |
| Total Equity | 2.37B | 2.22B | 2.74B | 2.09B | 1.16B |
| Total Debt | 11.98B | 11.82B | 11.12B | 12.07B | 15.05B |
| Net Debt | 11.51B | 11.58B | 10.74B | 11.27B | 14.29B |
DaVita Inc.
NYSE:DVA
Intrinsic Alpha fair value
Locked
Current Price
$161.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.